Company Analysis
Sign in

Pluri Inc. (PLUR)

Nasdaq: PLUR · Biological Products, (No Diagnostic Substances) · Haifa · filing with the SEC since 2001
Full chart Alerts Compare
Grade4.2
◀ Past 3.6● Present 3.7▶ Future 5.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2026, as filed
Revenue$1.0M-24.0%
Net income-$23.8M-5.5%
Earnings per share$-2.44+31.5%
Operating cash flow-$19.6M-7.6%
Cash$3.5M-40.1%
Debtn/a
Shareholders’ equity-$23.0M-236.7%
Shares, diluted9,743,913+53.8%
Return on equityn/a
The recordfrom its filings
Filings in 202638
Newest filingNov 12 · S-3/A
Annual reportSep 10, 2026
Quarterly reportNov 12, 2026
Next report due10-Q by Feb 14
Insider sales, 12 months$0.00
Insider buys, 12 months$1.3M
Patents granted1
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Revenue $1.5MNet income -$28.4MCash from operations -$18.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
17181920212223242526
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 30, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 27, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 20, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Oct 15, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Oct 6, 2026 · SEC EDGAR · Form S-1
Listing registration
Open the filing on sec.gov
Sep 11, 2026 · SEC EDGAR · Form S-3
Shelf registration
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PLUR · research, not advice